Navigation Links
Newsweek International Editions: Highlights And Exclusives, May 19, 2008
Date:5/11/2008

bility of resigning. "I don't really see that this will bring any better outcome for this country at this point. Not that a person is indispensable or irreplaceable. I don't believe in this. We are all human beings and there are many great guys in this country that can one day become prime ministers. But, given the circumstances right now, I think it will not do good that I step down at this point. I have to think about it."

http://www.newsweek.com/id/136105


'/>"/>
SOURCE Newsweek
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3).
2. International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece
3. MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
4. Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
5. Mindray Medical International Announces First Quarter 2008 Results
6. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
7. MINRAD International, Inc. Announces $40.0 Million Private Placement
8. Statement from Lighthouse International About the Study on Gene Therapy Concerning Lebers Congenital Amaurosis
9. Abbott Annual Meeting Highlights Outstanding 2007 Results, International Growth and Near-Term Pipeline
10. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
11. AANS/CNS and BrainLAB Announce Winner of 2008 International Research Fellowship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008).../ -- BioTrends Research Group, Inc.,released its 1...cation, a,syndicated report offering comprehensive...one and mineral metabolism in Chronic Kidney Disea...tion from 182 US,Nephrologists -- data were collec..., In the renal anemia market, while the use of ES...
(Date:7/25/2008)...rstCall/ -- Caraco Pharmaceutical,Laboratories, Lt...arter of,Fiscal 2009, ended June 30, 2008, of $108...orresponding period of Fiscal 2008. This represent...scal 2008. Pre-tax income grew,to $14.6 million fo...a,pre-tax income of $9.6 million during the corres...
(Date:7/25/2008)...ain Hearing in Both Ears for the First ...25 /- Cochlear, the world,s leader in...landmark milestone when,Dr. Thomas Roland, Jr., MD...0th cochlear implant device procedure. Today, 72-y...dergo surgery to receive bilateral (a,device in ea...
(Date:7/25/2008)...survey on creativity, sponsored by the Jerusalem-b...Teleseker, revealed that a majority of the Israeli...special methods that could "put them into a c...ong as desired." , J... survey on creativity, sponsored by the Jerusalem-...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 2Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 3Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 4Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3
... , New Advances in Scanner Design for Super..., , , The Affymetrix Gen...r continued evolution of the GeneChip platform a...g continued feature size reduction for higher reso...ay-based products. The Affymetrix GeneChip Scanner...
... Tunable Parameters of the Affymetrix Expressi...oduction , The Statistical Algorithms in ...set data to generate expression values (Signals an...ciated p-values for every transcript represented o...re used to generate transcript Detection and Chang...
...rometry Application Note , Melissa Chen, ...CA , Introduction , Rapid ide...ixtures is one of the key objectives for the use o...ionally, this approach has utilized 3-dimensional ...LCQ Deca XP Plus and the Finnigan ProteomeX. Recen...
...rometry Application Report , Key Words Se... Equine serum Acepromazine , Gargi Chou...SA , Wayne Skinner and Scott Stanley...oduction , Acepromazine is widely used a...r to better facilitate handling of these large mam...
Other Biology Technology:The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 2The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 3The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 4The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 5The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 6The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 7The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 8The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 9The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 10Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 2Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 3Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 4Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 5Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 6Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 7Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 8Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 9Fine Tuning Your Data Analysis:, Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms 10Complex Peptide Mixture Analysis on the Finnigan LTQ Linear Ion Trap Mass Spectrometer 2Complex Peptide Mixture Analysis on the Finnigan LTQ Linear Ion Trap Mass Spectrometer 3Complex Peptide Mixture Analysis on the Finnigan LTQ Linear Ion Trap Mass Spectrometer 4Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 2Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 3Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 4
(Date:7/24/2008)...w study by researchers from Columbia University,s ...he most challenging issues in infant health and pr...countries. In these settings, HIV-infected mother...heir infants, they should exclusively breast-feed,...ter birth. But according to the study conducted in...
(Date:7/24/2008)...4, 2008 In the life of a cell, the response to DN...ause and repair itself, commit suicide, or grow un...study, published in the July 25th issue of Cell ,...ntified a way that cells respond to DNA damage thr... The finding points to a new pathway for the devel...
(Date:7/24/2008)...AUL (July 24, 2008) A multi-institutional team of...ty of Minnesota Medical School, have developed a p...e robust method will allow researchers to generate...DNA sequences for inactivation or repair. , The p...Ph.D., director of the Arnold and Mabel Beckman Ce...
(Date:7/24/2008)...Y, Iowa The University of Iowa and Iowa State Uni...ly enhance both institutions, genetic research cap...hased a massively parallel DNA sequencer an instr...rate of millions to billions of bases in a single ... will be available on a fee-for-service basis to ...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3A new cellular pathway linked to cancer is identified by NYU researchers 2Consortium develops new method to manipulate genetic material 2UI and ISU establish shared DNA sequencing instrumentation 2UI and ISU establish shared DNA sequencing instrumentation 3New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 1New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 2New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 3New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 4New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 5Sinovac Announces Postponement of Annual General Meeting 115 1Sinovac Announces Postponement of Annual General Meeting 115 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 1Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 3Longer ambulance journeys boost death risk for seriously ill patients 116 1Longer ambulance journeys boost death risk for seriously ill patients 116 2
...ure climate shows that the Sahel region, which exp... in the 1990s, could experience wetter monsoons fo...n Africa is projected to intensify further. Oceani...e gases appears to be a factor in these expected 2...Hurrell of the National Center for Atmospheric Res...
...d other causes of Sick Building Syndrome may impro... American Phytopathological Society (APS). , Sick...which building occupants experience health problem... issues typically associated with SBS range from a...problems involving exposure to toxins. , Mold is a...
...in plant science. , Scientists have known since 1...ey,ve known of its dramatic effects on plant growt... scientists know how it works. , In this week,s Na...rk Estelle, Nihal Dharmasiri and Sunethra Dharmasi...influences how and when plant cells grow and divid...
...mols suppress the growth of human cell lines repre...ary, pancreas, brain and blood, and reduce tumors ...addition, Enigmols did not show side effects at ef... at the Georgia Institute of Technology, Emory Uni...re funded by the National Cancer Institute. , "Ma...
Other Biology News:Africa to take it on chin again with climate change 2Africa to take it on chin again with climate change 3What's really making you sick? Plant pathologists offer the science behind Sick Building Syndrome 2At long last, scientists figure out how plants grow 2Researchers find promising cancer-fighting power of synthetic cell-signaling molecule 2Researchers find promising cancer-fighting power of synthetic cell-signaling molecule 3
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST).
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048
Mouse monoclonal antibody raised against a partial recombinant EOMES. NCBI Entrez Gene ID = EOMES
LTQ XL Linear Ion Trap from Thermo Scientific
Biology Products: